Drugs.com

SEPTEMBER 19, 2024

19, 2024 -- The Hunan Seafood Wholesale wet market in Wuhan, China, has long been considered the most likely source of the coronavirus that caused the COVID-19 pandemic. THURSDAY, Sept. That theory is now supported by a new study analyzing more.

Marketing 105

Marketing 105

Science Daily: Pharmacology News

SEPTEMBER 19, 2024

A new study provides a list of the wildlife species present at the market from which SARS-CoV-2, the virus responsible for the COVID-19 pandemic, most likely arose in late 2019. The study is based on a new analysis of metatranscriptomic data released by the Chinese Center for Disease Control and Prevention (CDC).

Marketing 121

Marketing Virus Disease 121

Drug Patent Watch

SEPTEMBER 23, 2024

The generic drug market has experienced significant growth over the past few decades, driven by the expiration of patents on branded drugs and the increasing demand for affordable healthcare solutions. To succeed in this market, generic drug manufacturers must adopt innovative… Source

Marketing 80

Marketing Drugs 80

Perficient: Drug Development

APRIL 16, 2024

IDC Market Glance: Payer, 2Q24 Perficient is excited to be included in the IDC Market Glance: Payer, 2Q24 (doc #US51961724, April 2024) report. According to IDC, this report “provides a glance at the current makeup of the payer IT landscape, illustrates the vendor landscape, and depicts the segments and structure of the market.”

Marketing 107

Marketing Government 107

ProRelix Research

NOVEMBER 2, 2023

Limited patient populations, […] The post Post-Marketing Surveillance Strategies appeared first on ProRelix Research. Although clinical trials provide useful information regarding the efficacy and safety of new drugs, biological products, and medical devices, the information captured through them is not all-encompassing.

Marketing 98

Marketing Clinical Trials Trials Production 98

Perficient: Drug Development

SEPTEMBER 6, 2024

Salesforce’s position as a leader in this report reflects its current offerings, robust strategy, and strong market influence. Strategy: Forrester evaluates the vendor’s long-term vision, innovation roadmap, and ability to address future market needs.

Marketing 59

Marketing Compliance Production Engineering 59

Perficient: Drug Development

OCTOBER 8, 2024

One shining example is our recruitment strategy for Bayhealth, which was recently featured by the online publication, Strategic Health Care Marketing. Recognizing the need for a unified front, our team emphasized the importance of collaboration between HR and marketing.

Marketing 52

Marketing Testimonials Hospitals Science 52

Drug Patent Watch

JULY 25, 2024

The generic drug market has been significantly impacted by the COVID-19 pandemic, with both challenges and opportunities arising from the crisis. As the world continues to recover…

Marketing 91

Marketing Drugs 91

Perficient: Drug Development

SEPTEMBER 3, 2024

The world of Digital Marketing is challenging and always updating with new strategies. Gen AI can pump up your digital marketing efforts by creating highly engaged SEO-friendly content and boost your brand on SERP (Search Engine Result Page). What is Generative AI, and How Does it Work?

Marketing 52

Marketing Production Engineering Research 52

Perficient: Drug Development

OCTOBER 9, 2024

, Jim talks with Scott Brinker , VP of Platform Ecosystems at HubSpot and editor of the pioneering blog chiefmartec.com , about the evolving world of marketing technology (MarTech) and how marketers can stay ahead. Marketers now juggle a mix of platforms, from CMS and email marketing to LinkedIn and Generative AI.

Marketing 52

Marketing Production 52

Drugs.com

APRIL 4, 2024

THURSDAY, April 4, 2024 (HealthDayNews) -- Following disappointing trial results, the maker of a controversial ALS drug said it is pulling the medication off the market. In a statement issued Thursday, Amylyx Pharmaceuticals said that Relyvrio.

Marketing 111

Marketing Drugs Pharmaceuticals Trials 111

Fierce BioTech

OCTOBER 15, 2024

A Pharma Marketers' Roadmap to Data Privacy Compliance : Are You Ready for 2025? swheeler Tue, 10/15/2024 - 19:53 Thu, 11/21/2024 - 13:00 Resource Type Webinar Ben Chapman Duration 60 minutes Join for an insightful webinar on the evolving privacy landscape impacting pharma marketers in 2025.

Compliance 52

Compliance Marketing Regulations 52

Fierce BioTech

AUGUST 7, 2024

The Unfiltered Truth about AI & Pharma Marketing dwunderlin Wed, 08/07/2024 - 12:04 Wed, 09/04/2024 - 14:00 Resource Type Webinar Chris Cullmann Doug Barr Promotion Start Thu, 08/08/2024 - 15:00 Promotion End Sat, 02/08/2025 - 15:00 Duration 60 Minutes You need to know where artificial intelligence disrupts the pharmaceutical marketing norms.

Marketing 52

Marketing Pharmaceutical Companies Pharmaceuticals Production 52

Fierce BioTech

MARCH 15, 2024

Oncology Market Outlook 2024 This paper assesses the current state of the oncology market, reviewing key expectations for 2024. jpiatt Fri, 03/15/2024 - 13:46 This paper assesses the current state of the oncology market, reviewing key expectations for 2024.

Targeted Protein Degradation 52

Targeted Protein Degradation Marketing Therapies Science 52

Fierce BioTech

AUGUST 21, 2024

Market-Moving Trends to Watch in H2 2024 In a market defined by unpredictability, volatility, and fast-paced evolution, it can be challenging to determine where it’s heading and what executives should concern themselves with in the second half of 2024 and beyond. Interest in obesity drugs has led to billions of new prescriptions.

Marketing 52

Marketing Drugs 52

Collaborative Drug

APRIL 19, 2024

Tokyo, Japan, April 17, 2024 — In a significant move to bolster CDD Vault’s presence in the Japanese market, Collaborative Drug Discovery (CDD) is excited to announce the appointment of Mr. Yasushi Hamagashira as the new Head of Sales and Marketing for Japan.

Marketing 101

Marketing Drugs 101

Fierce BioTech

FEBRUARY 21, 2024

CNS Market Outlook, 2024 This paper assesses the current state of the broad CNS market, reviewing key expectations for 2024. It also provides a high-level look at the pain market and the evolving regulatory environment. It addresses Alzheimer’s disease, biomarkers, and advances in psychiatry in detail.

Marketing 52

Marketing Science Disease 52

Drug Patent Watch

JULY 1, 2024

Lipitor’s marketing strategy underwent a significant evolution as generic competition emerged, employing aggressive tactics to retain market share and brand […] Source

Marketing 81

Marketing Pharmaceuticals 81

Cytel

MAY 7, 2024

Here we explore the evolution and impact of market exclusivity policies in the EU and US, highlighting their role in fostering innovation and accessibility in rare disease treatment. Market exclusivity for orphan drugs traces back to the early 1980s in the United States, with the landmark Orphan Drug Act of 1983.

Marketing 59

Marketing Production Drugs Disease 59

Fierce BioTech

SEPTEMBER 24, 2024

Unlocking European market access for rare disease therapies The European orphan drug market presents a significant opportunity for biotech firms. Learn more about early access programs (EAPs), and how they are emerging as a critical strategy for successfully launching rare disease therapies in this complex and diverse market.

Marketing 40

Marketing Therapies Disease Drugs 40

Perficient: Drug Development

JULY 11, 2024

Now, as part of the latest release, Salesforce have released Marketing Cloud Engagement link shortener. Marketing Cloud Engagement link shortener is enabled only for Hyperforce users for now. For this, you would have used bitly in the past. This utilizes AWS to shorten the URLs. References: [link]

Marketing 52

Marketing 52

Perficient: Drug Development

JANUARY 16, 2024

Personalization (formerly known as Interaction Studio) is a tool that exists inside the Salesforce Marketing Cloud tenant. In this case, we want to know where the user is for marketing and statistical purposes, and not punish our user in the same way Lotso wants to catch the toys. The sitemap is the heart of personalization.

Marketing 64

Marketing Production 64

Perficient: Drug Development

SEPTEMBER 6, 2024

IDC Market Glance: Customer Experience Services, 3Q24 Perficient is excited to announce that we have been included in the IDC Market Glance: Customer Experience Services, 3Q24, doc # US51521224, August 2024 report.

Marketing 52

Marketing Science 52

Drugs.com

MARCH 11, 2024

MONDAY, March 11, 2024 -- Following disappointing trial results, the maker of a controversial ALS drug may pull the medication off the market. In a statement issued Friday, Amylyx Pharmaceuticals said that Relyvrio failed to help patients in a.

Marketing 115

Marketing Trials Drugs Pharmaceuticals 115

Fierce BioTech

JUNE 18, 2024

Experts recommend that CGT manufacturers proactively design a comprehensive market access strategy early in clinical development and commercial planning timelines, ideally more than three years pri | CGT companies should consider developing a market access strategy early in clinical development, ideally more than three years prior to launch.

Marketing 75

Marketing Clinical Development 75

BioPharma Drive: Drug Pricing

OCTOBER 23, 2023

Effective marketing measurement requires objectivity, connected data, transparency, a track record of innovation and a proven ability to execute.

Marketing 109

Marketing 109

Perficient: Drug Development

JULY 11, 2024

The e-commerce market is more diverse and complex than ever, with businesses facing the challenge of navigating an array of software options, from AI-powered personalization engines to blockchain-based payment systems. According to IDC, “The core of Essential Digital Commerce Applications is the specialty of this market.

Marketing 52

Marketing Engineering Production 52

FDA Law Blog: Biosimilars

SEPTEMBER 26, 2024

In fact, it has a whole page dedicated to “CDRH Innovation,” which states that CDRH “is committed to advancing public health by helping to bring innovative technologies to market.” Manufacturers can expect increased interaction with the review team and prioritized review of the marketing submission.” So what can be done?

Marketing 64

Marketing Clinical Trials FDA Trials 64

Fierce BioTech

AUGUST 26, 2024

Pharma Marketing Trends: Key Takeaways from Digital Pharma East 2024 swheeler Mon, 08/26/2024 - 14:05 Thu, 09/26/2024 - 13:00 Resource Type Webinar Stephanie Butler Promotion Start Tue, 08/27/2024 - 14:15 Promotion End Thu, 02/27/2025 - 14:15 Duration 60 minutes Did you miss the buzz at Digital Pharma East 2024?

Marketing 52

Marketing Disease 52

Drugs.com

JULY 19, 2024

FRIDAY, July 19, 2024 -- The U.S. Food and Drug Administration on Thursday authorized the sale of the country's best-selling e-cigarette.The agency's decision only applies to several tobacco-flavored versions of the reusable product, sold as Vuse.

Marketing 105

Marketing FDA Production Drugs 105

ProRelix Research

DECEMBER 27, 2022

The post USA Clinical Trial Market Size and Opportunities appeared first on ProRelix Research. Clinical trials form the crux of all regulatory decisions regarding any new health intervention such as drugs and medical devices and thus require to be performed with the utmost care […].

Clinical Trials 98

Clinical Trials Marketing Trials Research 98

Antidote

MAY 10, 2024

While it is most commonly used in relation to art generators or web searches, AI has many practical applications beyond these uses — especially within the clinical trial marketing space.

Clinical Trials 52

Clinical Trials Marketing Trials 52

Drugs.com

OCTOBER 10, 2023

They are marketed with. MONDAY, Oct. 9, 2023 -- Flavoring added to small, cheap cigars is making these the second-most popular tobacco product among youth, a new report shows. The report comes as federal regulators prepare to bar flavored cigars.

Marketing 105

Marketing Regulations Production 105

Drug Channels

NOVEMBER 10, 2023

Today’s guest post comes from James Pisano, Partner, Market Access at The Dedham Group and Dinesh Kabaleeswaran, SVP of Insights & Advisory Teams at MMIT. James and Dinesh offer four trends that they predict will shape medication access in the coming years.

Marketing 97

Marketing Drugs 97

BioPharma Drive: Drug Pricing

AUGUST 8, 2023

The Indianapolis drugmaker is now worth more than $500 billion, higher than any other pharmaceutical company, as analysts project lucrative markets for its obesity and Alzheimer's drugs.

Marketing 98

Marketing Pharmaceutical Companies Drugs Pharmaceuticals 98

Fierce BioTech

MARCH 19, 2024

Cookieless Marketing of Pharmaceuticals Requires Real-World Data Pharma ads face uncertainty with fading third-party cookies. Adapting to cookieless marketing means integrating real-world data into all campaign phases, demanding close collaboration and reliance on new data sources for effective targeting. Download now. Download now.

Marketing 52

Marketing Pharmaceuticals 52

Perficient: Drug Development

OCTOBER 31, 2023

Marketing Cloud is a powerful business tool to create, manage, and optimize marketing campaigns. However, getting hands-on experience with Marketing Cloud can be challenging, as it doesn’t provide demo environments or Trailhead hands-on challenges. What Is Salesforce Marketing Cloud?

Marketing 59

Marketing 59